• Request An Appointment
  • Get Directions
  • Patient Portal
  • Online Bill Pay
DR. JEFFREY NATHANSON joins our team FEBRUARY 2021! Accepting appointments NOW!
HealthFlex

Contact Us: (224) 407-4400 or Email Us

×
  • Home
  • About
  • Services
  • Procedures
  • Staff
  • Patient Resources
    • GI Health Blog
    • Patient Portal
    • Telehealth Visits
    • COVID-19 PROTOCOL
    • Patient Forms
    • Accepted Insurance Plans
    • Medicare Policy & Forms
    • Fee Schedule
    • Patient Education Links
    • Patient Testimonials
    • Patient Feedback Form
  • FAQ
  • Contact
    • Book an Appointment

ASPIRIN MAY REDUCE COLON CANCER RISK BY ALTERING GUT MICROBIOME

ASPIRIN MAY REDUCE COLON CANCER RISK BY ALTERING GUT MICROBIOME
September 14, 2020Dr. Tara TroyBrowse by Staff MemberColonTARA TROY, M.D. GastroenterologistThe Gastrointestinal SystemsGut Microbiome

ASPIRIN MAY REDUCE COLON CANCER RISK BY ALTERING GUT MICROBIOME

 

Check out this recent study in Alimentary Pharmacology and Therapeutics showing that aspirin’s decreased risk of colorectal cancer (CRC) may potentially occur by modulating the gut microbiome.

AP&T: Randomised clinical study: oral aspirin 325 mg daily vs placebo alters gut microbial composition and bacterial taxa associated with colorectal cancer risk

 

 

“Aspirin, an accessible and affordable drug, is one of the most intriguing prospects for cancer prevention. In 2016, the U.S. Preventive Services Task Force recommended using low‐dose aspirin (81 mg) to reduce cardiovascular disease (CVD) and colorectal cancer (CRC) risk among adults aged 50‐59 with a 10% increased CVD risk. Currently, more than 30% of adults over the age of 40 reported taking low‐dose aspirin for primary or secondary CVD prevention; this translates into almost 39 million aspirin users in the U.S.”

“In addition to preventing CVD, aspirin use may protect against CRC development. In randomised clinical trials, aspirin use was associated with a reduction in CRC risk by 24%‐38%. However, aspirin has not been recommended for population‐based prevention in healthy people because of aspirin’s side effects (eg gastrointestinal bleeding and cerebral haemorrhage) in some individuals and lack of understanding about population subgroups in which aspirin decreases CRC risk but does not cause adverse reactions.Tailoring aspirin to individuals who will especially benefit from using this drug for CRC prevention is one of the current priorities in cancer research in the U.S.”

 

“Aspirin modulates inflammation and immune response via cyclooxygenase (COX)‐dependent and ‐independent mechanisms. However, the exact mechanisms through which aspirin reduces risk of colorectal neoplasia and the molecular targets of aspirin in the context of CRC prevention have not been established.”

This study demonstrated that “compared to placebo, aspirin intake influenced several microbial taxa (Ruminococcaceae, Clostridium XlVa, Parabacteroides and Dorea) in a direction consistent with a priori hypothesis based on their association with CRC. This suggests that aspirin may influence CRC development through an effect on the gut microbiome. The findings need replication in a larger trial.”

 

Don’t start taking aspirin quite yet though! Basically, more carefully designed larger trials need to be performed before recommending routine use of aspirin for colon polyp/cancer prevention. As well, aspirin can have dangerous adverse effects and you need to check with your doctor if aspirin is a safe choice for you! However, it is always heartening to learn of any potential new strategies to help combat the second most common cause of cancer deaths.

For today, a friendly reminder about the importance of colon cancer screening. FACT: Colorectal cancer is the MOST PREVENTABLE but LEAST PREVENTED cancer. Is it time for you to get screened?? Did you know that the American Cancer Society is recommending that ALL individuals begin screening at age 45?? We would be happy to help get you up to date with the latest colon cancer screening recommendations.

 

Call 224.407.4400 or email info@compgihealth.com for a procedure or consultation appointment now (evening and Saturday hours are available!).

  • Author
  • Recent Posts
Dr. Tara Troy
Dr. Tara Troy
Dr. Troy is a gastroenterologist who absolutely loves learning and then sharing new knowledge in an easily digestible manner. Colon cancer prevention, Crohn’s disease and ulcerative colitis, and functional GI conditions like irritable bowel syndrome and functional dyspepsia are topics that she finds fascinating.
Dr. Tara Troy
Latest posts by Dr. Tara Troy (see all)
  • ENVIRONMENTAL CHEMICAL EXPOSURE TIED TO CELIAC DISEASE - October 30, 2020
  • THE POWER OF FLAVANOLS! - October 28, 2020
  • HUGE NEWS!! We are so thrilled to officially welcome DR. JEFFREY NATHANSON to the Comprehensive Gastrointestinal Health team starting February 2021 - October 21, 2020

Add Comment Cancel


Looking For Something?

Welcome to Our Blog

Our experienced team of caregivers compile daily blog posts to help educate our patients and our website visitors about GI health related topics. We hope you enjoy following along!

Recent Posts

  • ENVIRONMENTAL CHEMICAL EXPOSURE TIED TO CELIAC DISEASE October 30, 2020
  • THE POWER OF FLAVANOLS! October 28, 2020
  • Small, Short-Term Weight Loss Goals = Long-Term Success October 26, 2020
  • HUGE NEWS!! We are so thrilled to officially welcome DR. JEFFREY NATHANSON to the Comprehensive Gastrointestinal Health team starting February 2021 October 21, 2020
  • 11 REFRESHING ALTERNATIVES TO SODA October 16, 2020

Browse by Tag

Alzheimer's Anxiety C. Diff Celiac Disease Colonoscopy Constipation COVID-19 Crohn’s Disease Dementia Depression Diabetes Diarrhea Diet & Nutrition Diverticulitis Exercise & Fitness Fatty Liver Disease Gut Microbiome Hepatocellular carcinoma Hypnotherapy Inflammatory Bowel Disease (IBD) Irritable Bowel Syndrome (IBS) Mental Health Mind-Gut Connection Obesity Pre- & Probiotics Psychogastroenterology Ulcerative Colitis

Categories

  • Anxiety, Depression & Mental Health (57)
  • Browse by Staff Member (339)
    • CLAIRE ALLEN, MS, RDN, LDN (30)
    • JAMES “JED” FOSTER, JR., MA, LMFT (32)
    • JEFFREY NATHANSON, M.D. Gastroenterologist (1)
    • JEN BUETTNER, RN (4)
    • JILL LINDER, RN (6)
    • JOLIE DICKSON (1)
    • LEAH REMMERS, RN (3)
    • LIBBY BURGER, RN (1)
    • LIZ MOON, NP (32)
    • SHAYNE WELCH, Physical Therapist (4)
    • TARA TROY, M.D. Gastroenterologist (224)
  • Diet, Exercise & Healthy Living (168)
  • Fatty Liver Disease (5)
  • Inflammatory Bowel Disease (IBD) (25)
  • Irritable Bowel Syndrome (IBS) (37)
  • Latest News (40)
  • Meet Our Staff (10)
  • The Gastrointestinal Systems (85)
    • Colon (52)
    • Liver (7)
  • Uncategorized (1)

Share With Your Friends & Family

RSS
Follow by Email
Facebook
fb-share-icon
Instagram

Quality, safety, and efficiency in a convenient and comfortable environment. We listen carefully. We evaluate meticulously. Then we provide COMPREHENSIVE personalized care of exceptional caliber with innovative strategies, cutting edge techniques, and sincere compassion. Come visit and see for yourself. We are conveniently located in Northbrook and easy to get to from surrounding areas including Glenview, Glencoe, and Highland Park, IL.

Office (224) 407-4400 | Fax (224) 407-2255

info@compgihealth.com

https://compgihealth.com

40 Skokie Boulevard, Suite 110, Northbrook, Illinois 60062

Quick Links

  • Contact
  • Hours & Directions
  • Request An Appointment
  • Accepted Insurance Plans
  • Patient Forms
  • Patient & Visitor Guide
  • Patient Testimonials
  • FAQ
  • Terms & Conditions
  • Privacy Policy
  • Northwestern Private Practice

Security & Privacy

GI Health Blog

  • ASPIRIN MAY REDUCE COLON CANCER RISK BY ALTERING GUT MICROBIOME Sep 14
  • ASPIRIN MAY REDUCE COLON CANCER RISK BY ALTERING GUT MICROBIOME Sep 14
  • ASPIRIN MAY REDUCE COLON CANCER RISK BY ALTERING GUT MICROBIOME Sep 14
  • ASPIRIN MAY REDUCE COLON CANCER RISK BY ALTERING GUT MICROBIOME Sep 14
  • ASPIRIN MAY REDUCE COLON CANCER RISK BY ALTERING GUT MICROBIOME Sep 14
Copyright ©2019. All rights reserved.